SOX2 and breast carcinoma: However, a study by Liu et al. (Liu et al., 2019) using breast cancer decellularized scaffolds repopulated with MCF7 cells described a significant decrease in CSC markers as POU5F1, SOX2, and CD49F after treatment with 5‐FU.